These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37089845)
1. Bimatoprost versus Clobetasol Propionate in Scalp Alopecia Areata: A Prospective Non-Randomized Open-Label Clinical Trial. Bhusal M; Bhattarai S; Thapa B; Shrestha PR; Sagar GC Indian Dermatol Online J; 2023; 14(2):221-225. PubMed ID: 37089845 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. Tosti A; Iorizzo M; Botta GL; Milani M J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039 [TBL] [Abstract][Full Text] [Related]
3. Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial. Ali MS; Hafiz HSA; Ahmed NA; Galal SA J Cosmet Dermatol; 2023 Apr; 22(4):1286-1296. PubMed ID: 36762396 [TBL] [Abstract][Full Text] [Related]
4. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial. Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568 [TBL] [Abstract][Full Text] [Related]
5. The comparison of therapeutic effect of Clobetasol propionate lotion and squill extract in alopecia areata: a randomized, double-blind clinical trial. Moosavi ZB; Aliabdi M; Golfakhrabadi F; Namjoyan F Arch Dermatol Res; 2020 Apr; 312(3):173-178. PubMed ID: 31707498 [TBL] [Abstract][Full Text] [Related]
6. Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study. Zaher H; Gawdat HI; Hegazy RA; Hassan M Dermatology; 2015; 230(4):308-13. PubMed ID: 25765294 [TBL] [Abstract][Full Text] [Related]
7. The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double-blind placebo-controlled trial. Rafati M; Mahmoudian R; Golpour M; Kazeminejad A; Saeedi M; Nekoukar Z Dermatol Ther; 2022 Jun; 35(6):e15450. PubMed ID: 35289043 [TBL] [Abstract][Full Text] [Related]
8. The role of fractional laser-assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra-patient comparative randomized clinical trial. Meymandi SS; Safari A; Meymandi MS; Aflatoonian M J Cosmet Dermatol; 2024 May; 23(5):1663-1668. PubMed ID: 38321929 [TBL] [Abstract][Full Text] [Related]
9. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016 [TBL] [Abstract][Full Text] [Related]
10. Comparative study between topical steroid alone versus combined fractional Erbium:YAG laser with topical steroid in treatment of alopecia areata. Shokeir HA; Yousry A; Ibrahim SMA Arch Dermatol Res; 2023 Mar; 315(2):241-247. PubMed ID: 36264329 [TBL] [Abstract][Full Text] [Related]
11. The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata. Ucak H; Kandi B; Cicek D; Halisdemir N; Dertlıoğlu SB J Dermatolog Treat; 2012 Dec; 23(6):410-20. PubMed ID: 21787210 [TBL] [Abstract][Full Text] [Related]
12. Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study. Bokhari L; Sinclair R Int J Dermatol; 2018 Dec; 57(12):1464-1470. PubMed ID: 30160787 [TBL] [Abstract][Full Text] [Related]
13. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review. Brown L; Skopit S J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734 [TBL] [Abstract][Full Text] [Related]
14. Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study. Ricar J; Cetkovska P; Hordinsky M; Ricarova R Dermatol Ther; 2022 Jun; 35(6):e15438. PubMed ID: 35278027 [TBL] [Abstract][Full Text] [Related]
15. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study. Lalosevic J; Gajic-Veljic M; Bonaci-Nikolic B; Nikolic M Dermatol Ther; 2015; 28(5):309-17. PubMed ID: 26179196 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors that affect the response to topical treatment in patchy alopecia areata. Ucak H; Cicek D; Demir B; Erden I; Ozturk S J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):34-40. PubMed ID: 23181708 [TBL] [Abstract][Full Text] [Related]
18. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study. Almutairi N; Nour TM; Hussain NH Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941 [TBL] [Abstract][Full Text] [Related]
19. Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials. Piraccini BM; Ohyama M; Craiglow B; Bewley A; Ding Y; Chen YF; Dutronc Y; Pierce E; Durand F; Mostaghimi A J Dermatolog Treat; 2023 Dec; 34(1):2227299. PubMed ID: 37381691 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Efficacy of Topical Betamethasone Dipropionate and Topical Minoxidil in Patients With Alopecia Areata. Aslam S; Awan AZ; Iqbal MM; Saeed S; Saeed M; Liaqat Z; Dar SA; Ali S; Asif MA; Mehmood Qadri H Cureus; 2024 Mar; 16(3):e56282. PubMed ID: 38623137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]